Joe Rogan Experience #2537 - David Sinclair
8 claims didn't hold up. False, distorted, or one-sided. Unverified claims don't count against it.
A few needed a second look. About what three hours of talking gets you.
Claim by claim(10 claims flagged)
The book 'Lifespan' was published in 2019 and has been translated into 40 languages.
David Sinclair's book 'Lifespan' really was published in 2019, that part checks out. The 40 languages figure is harder to pin down. The only public count we could find was an old 2019 pre launch report of 18 languages, and since translation deals keep getting signed for years after a book comes out, that old number doesn't actually contradict a current count of 40. We couldn't find a source confirming today's total either way.
Shinya Yamanaka won the Nobel Prize in 2006 for discovering four genes that convert adult cells into stem cells.
Shinya Yamanaka won the Nobel Prize in Physiology or Medicine in 2012, not 2006, for showing that mature cells can be reprogrammed into pluripotent stem cells. He did first report making mouse iPS cells in 2006, but the prize itself came six years later.
Approximately 40 million people in the United States suffer from glaucoma.
CDC-backed research, a 2022 study published in JAMA Ophthalmology, puts the number of Americans with glaucoma at about 4.2 million, with roughly 1.5 million having vision-affecting glaucoma. Forty million overstates that by close to tenfold.
Researchers in China utilized OSK technology to successfully regrow muscle and bone in mice with joint damage.
A real study out of Central South University in China did use OSK gene therapy in mice with damaged joints, so the basic story checks out. But the study's actual findings were about protecting cartilage and normalizing bone density changes around the joint, not fully regrowing muscle and bone back to normal the way the claim describes.
Research conducted in Dr. David Sinclair's lab has demonstrated the ability to reverse the age of human skin cells to a biological equivalent of approximately 25 years old using OSK genes.
Sinclair's lab has published real, peer reviewed research showing OSK gene therapy can dramatically reverse the biological age of cells, including work restoring youth to damaged neurons and aged mouse tissue. But we couldn't find a published study matching this specific claim, reprogramming a 92 year old donor's human skin cells down to a biological age of 25. It may reflect newer lab results not yet published, but we can't confirm the exact figures.
Alzheimer's disease can be reversed by making the brain younger.
There's genuine research into reversing brain aging through epigenetic reprogramming, and Sinclair has said he believes this could one day help Alzheimer's patients. But right now there's no cure or reversal for Alzheimer's disease, only treatments that can slow its progression, so stating it 'can be reversed' overstates where the science actually stands today.
The Harvard Study of Adult Development, led by Robert Waldinger, tracked World War II veterans for decades to identify predictors of longevity.
The Harvard Study of Adult Development did track many men who went on to serve in World War II, but it wasn't a study built around veterans. It began in 1938 following two separate groups, Harvard undergraduates and disadvantaged Boston youths, defined by their backgrounds rather than by military service.
Centenarians typically possess a good sense of humor and have not been overweight.
There's real research behind parts of this. A 2024 systematic review found most centenarians were normal weight or underweight, with only about 14% overweight and 4% obese, and separate research on centenarians has documented traits like optimism and extroversion. But stating a good sense of humor and never being overweight as defining traits overstates how consistent this actually is, since a meaningful share of centenarians don't fit that mold and personality profiles vary widely.
Jeff Bezos's company Altos Labs is working on longevity research with billions of dollars in funding.
Altos Labs really is a longevity research company with billions in funding, about $3 billion at launch, and Jeff Bezos is one of its most prominent backers. But calling it 'Bezos's company' overstates his role, since it launched with multiple investors, including billionaire Yuri Milner, rather than being built or owned by Bezos alone.
A 2012 study showed that NMN allows animals to grow new blood vessels by eliminating a protein that accumulates with age.
The Sinclair lab study on NMN restoring blood vessel growth in older mice was published in Cell in 2018, not 2012, and the mechanism involved restoring an NAD+ dependent signaling pathway rather than simply eliminating one protein. Treated mice regained capillary density and saw a 56 to 80 percent boost in endurance.
All of this ran on its own. The claims got pulled out of the transcript, then checked against live sources.
This can get things wrong. Follow the sources and decide for yourself.
Get the check before you finish the episode.
JRE drops four or five episodes a week. We check every one and send a short note with the Jamie Meter and the claims that didn't hold up.